Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996512592> ?p ?o ?g. }
- W1996512592 endingPage "567" @default.
- W1996512592 startingPage "561" @default.
- W1996512592 abstract "Objective The atherosclerotic process is driven by elevated Low-density lipoprotein (LDL)-cholesterol in combination with enhanced inflammatory responses. Several mediators participate in this complex inflammatory network including members of the tumour necrosis factor (receptor) superfamily. Familial hypercholesterolemia (FH) is associated with increased risk of developing premature atherosclerosis. Statin treatment may normalize LDL-cholesterol levels, but it is not known if the inflammatory responses are normalized in statin-treated FH patients. Methods In long-term statin-treated FH subjects (n = 33) and healthy controls (n = 10) the expression of tumour necrosis factor (receptor) superfamily related genes in peripheral blood mononuclear cells (PBMC) were analyzed by real-time quantitative RT-PCR. TNFα release was measured in PBMC from patients and controls by immunoassay. Results In FH patients with normal LDL-cholesterol, after a median of 17 years of statin treatment, our major findings were: (i) Gene expression of CD137, LIGHT (lymphotoxins inducible expression, competes with HSV glycoprotein D for HVEM, a receptor expressed on T-lymphocytes), HVEM (Herpesvirus entry mediator), the two TNFα Receptors (TNFR1 and TNFR2), TNF related apoptosis inducing ligand (TRAIL) and CD40 were increased in PBMC from FH patients compared to controls. (ii) The release of TNFα in PBMC from FH patients, in response to LPS was increased compared to controls. (iii) PBMC from FH patients had enhanced spontaneous release of TNFα when incubated in the presence of control serum and in particular in the presence of FH serum. Conclusion Despite long-term statin therapy, an increased expression of several TNF related genes in PBMC isolated from FH patients was observed. Our findings may implicate a pathogenic role for inflammation and TNF related molecules in FH, and these findings suggest the possibility that novel treatment modalities beyond that of statins and lipid lowering drugs may be useful in FH subjects." @default.
- W1996512592 created "2016-06-24" @default.
- W1996512592 creator A5002493858 @default.
- W1996512592 creator A5005242924 @default.
- W1996512592 creator A5006674792 @default.
- W1996512592 creator A5009401009 @default.
- W1996512592 creator A5009467334 @default.
- W1996512592 creator A5030407697 @default.
- W1996512592 creator A5030535599 @default.
- W1996512592 creator A5053349306 @default.
- W1996512592 creator A5061274063 @default.
- W1996512592 creator A5076836210 @default.
- W1996512592 date "2014-04-01" @default.
- W1996512592 modified "2023-10-18" @default.
- W1996512592 title "Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment" @default.
- W1996512592 cites W1988731031 @default.
- W1996512592 cites W2007684714 @default.
- W1996512592 cites W2008960002 @default.
- W1996512592 cites W2033669311 @default.
- W1996512592 cites W2034644316 @default.
- W1996512592 cites W2042489459 @default.
- W1996512592 cites W2044059149 @default.
- W1996512592 cites W2044338450 @default.
- W1996512592 cites W2044509575 @default.
- W1996512592 cites W2076133376 @default.
- W1996512592 cites W2081611571 @default.
- W1996512592 cites W2084744450 @default.
- W1996512592 cites W2086969742 @default.
- W1996512592 cites W2091050865 @default.
- W1996512592 cites W2094909314 @default.
- W1996512592 cites W2095197471 @default.
- W1996512592 cites W2097115452 @default.
- W1996512592 cites W2097426078 @default.
- W1996512592 cites W2104211766 @default.
- W1996512592 cites W2105612671 @default.
- W1996512592 cites W2107277218 @default.
- W1996512592 cites W2109397913 @default.
- W1996512592 cites W2118581125 @default.
- W1996512592 cites W2119972342 @default.
- W1996512592 cites W2123415255 @default.
- W1996512592 cites W2126372860 @default.
- W1996512592 cites W2137983259 @default.
- W1996512592 cites W2155598961 @default.
- W1996512592 cites W2160152341 @default.
- W1996512592 cites W2161453510 @default.
- W1996512592 cites W2166038501 @default.
- W1996512592 cites W2294579566 @default.
- W1996512592 cites W424467158 @default.
- W1996512592 cites W4249898731 @default.
- W1996512592 doi "https://doi.org/10.1016/j.atherosclerosis.2014.01.022" @default.
- W1996512592 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24530965" @default.
- W1996512592 hasPublicationYear "2014" @default.
- W1996512592 type Work @default.
- W1996512592 sameAs 1996512592 @default.
- W1996512592 citedByCount "42" @default.
- W1996512592 countsByYear W19965125922014 @default.
- W1996512592 countsByYear W19965125922015 @default.
- W1996512592 countsByYear W19965125922016 @default.
- W1996512592 countsByYear W19965125922017 @default.
- W1996512592 countsByYear W19965125922018 @default.
- W1996512592 countsByYear W19965125922019 @default.
- W1996512592 countsByYear W19965125922020 @default.
- W1996512592 countsByYear W19965125922021 @default.
- W1996512592 countsByYear W19965125922022 @default.
- W1996512592 countsByYear W19965125922023 @default.
- W1996512592 crossrefType "journal-article" @default.
- W1996512592 hasAuthorship W1996512592A5002493858 @default.
- W1996512592 hasAuthorship W1996512592A5005242924 @default.
- W1996512592 hasAuthorship W1996512592A5006674792 @default.
- W1996512592 hasAuthorship W1996512592A5009401009 @default.
- W1996512592 hasAuthorship W1996512592A5009467334 @default.
- W1996512592 hasAuthorship W1996512592A5030407697 @default.
- W1996512592 hasAuthorship W1996512592A5030535599 @default.
- W1996512592 hasAuthorship W1996512592A5053349306 @default.
- W1996512592 hasAuthorship W1996512592A5061274063 @default.
- W1996512592 hasAuthorship W1996512592A5076836210 @default.
- W1996512592 hasConcept C126322002 @default.
- W1996512592 hasConcept C134018914 @default.
- W1996512592 hasConcept C137061746 @default.
- W1996512592 hasConcept C170493617 @default.
- W1996512592 hasConcept C17991360 @default.
- W1996512592 hasConcept C202751555 @default.
- W1996512592 hasConcept C203014093 @default.
- W1996512592 hasConcept C2776839432 @default.
- W1996512592 hasConcept C2776914184 @default.
- W1996512592 hasConcept C2778163477 @default.
- W1996512592 hasConcept C2779120738 @default.
- W1996512592 hasConcept C2780072125 @default.
- W1996512592 hasConcept C43554185 @default.
- W1996512592 hasConcept C55493867 @default.
- W1996512592 hasConcept C71924100 @default.
- W1996512592 hasConcept C86803240 @default.
- W1996512592 hasConceptScore W1996512592C126322002 @default.
- W1996512592 hasConceptScore W1996512592C134018914 @default.
- W1996512592 hasConceptScore W1996512592C137061746 @default.
- W1996512592 hasConceptScore W1996512592C170493617 @default.
- W1996512592 hasConceptScore W1996512592C17991360 @default.
- W1996512592 hasConceptScore W1996512592C202751555 @default.